Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fulminant babesiosis treated with clindamycin, quinine,and whole‐blood exchange transfusion

Identifieur interne : 002545 ( Main/Exploration ); précédent : 002544; suivant : 002546

Fulminant babesiosis treated with clindamycin, quinine,and whole‐blood exchange transfusion

Auteurs : S. E. Dorman [États-Unis] ; M. E. Cannon [États-Unis] ; S. R. Telford Iii [États-Unis] ; K. M. Frank [États-Unis] ; W. H. Churchill [États-Unis]

Source :

RBID : ISTEX:3652D775AFC677FB155E1966B626914EE41B459C

English descriptors

Abstract

BACKGROUND: Babesiosis is an increasingly recognized parasitic infection with manifestations that range from a subclinical or mild flu‐like illness to life‐threatening disease. Risk factors that may be associated with a more severe clinical course include immunosuppression, splenectomy, and advanced age. The most effective chemotherapeutic regimen, clindamycin plus quinine, is sometimes ineffective in cases of severe disease. CASE REPORT: A previously healthy, 58‐year‐old man was infected by Babesia microti, presumably through a tick bite. He developed fulminant disease characterized by severe hemolytic anemia, disseminated intravascular coagulation, acute renal failure, and respiratory failure. There was no history of splenectomy or immunodeficiency. He was given oral clindamycin (300 mg/4×/day) 2 days before admission. Oral quinine (650 mg/3×/day) was added upon hospitalization. There was no clinical improvement despite antibiotic therapy with clindamycin and quinine. On the second hospital day, a whole‐blood exchange transfusion was performed to simultaneously lower the parasite load and replace the patient's plasma. With an automated blood cell separator, 87 percent of the patient's total blood volume was exchanged. As replacement fluid, 6.7 L of packed RBCs reconstituted with FFP (average Hct, 33%) was used. The patient's Hct increased from 26.9 percent before the exchange to 28.3 percent after the exchange. The percentage of parasitized RBCs decreased from 13.8 percent just before exchange to 4.2 percent immediately after exchange. There was rapid clinical improvement after the whole‐blood exchange transfusion. The patient's subsequent clinical course was marked by a disappearance of the parasitemia and continued slow, general improvement. Therapy with clindamycin was continued for 14 days after the exchange transfusion and quinine for 17 days. CONCLUSION: In cases of severe babesiosis, prompt institution of whole‐blood exchange transfusion, in combination with appropriate antimicrobial therapy, can be life‐saving.

Url:
DOI: 10.1046/j.1537-2995.2000.40030375.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fulminant babesiosis treated with clindamycin, quinine,and whole‐blood exchange transfusion</title>
<author>
<name sortKey="Dorman, S E" sort="Dorman, S E" uniqKey="Dorman S" first="S. E." last="Dorman">S. E. Dorman</name>
</author>
<author>
<name sortKey="Cannon, M E" sort="Cannon, M E" uniqKey="Cannon M" first="M. E." last="Cannon">M. E. Cannon</name>
</author>
<author>
<name sortKey="Telford Iii, S R" sort="Telford Iii, S R" uniqKey="Telford Iii S" first="S. R." last="Telford Iii">S. R. Telford Iii</name>
</author>
<author>
<name sortKey="Frank, K M" sort="Frank, K M" uniqKey="Frank K" first="K. M." last="Frank">K. M. Frank</name>
</author>
<author>
<name sortKey="Churchill, W H" sort="Churchill, W H" uniqKey="Churchill W" first="W. H." last="Churchill">W. H. Churchill</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3652D775AFC677FB155E1966B626914EE41B459C</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1046/j.1537-2995.2000.40030375.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-2FMKHXT2-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001514</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001514</idno>
<idno type="wicri:Area/Istex/Curation">001514</idno>
<idno type="wicri:Area/Istex/Checkpoint">001363</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001363</idno>
<idno type="wicri:doubleKey">0041-1132:2000:Dorman S:fulminant:babesiosis:treated</idno>
<idno type="wicri:Area/Main/Merge">002573</idno>
<idno type="wicri:Area/Main/Curation">002545</idno>
<idno type="wicri:Area/Main/Exploration">002545</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Fulminant babesiosis treated with clindamycin, quinine,and whole‐blood exchange transfusion</title>
<author>
<name sortKey="Dorman, S E" sort="Dorman, S E" uniqKey="Dorman S" first="S. E." last="Dorman">S. E. Dorman</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>From the Division of Hematology, Department of Medicine, and the Department of Pathology, Brigham and Women's Hospital; and the Department of Tropical Public Health, Harvard School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Cannon, M E" sort="Cannon, M E" uniqKey="Cannon M" first="M. E." last="Cannon">M. E. Cannon</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>From the Division of Hematology, Department of Medicine, and the Department of Pathology, Brigham and Women's Hospital; and the Department of Tropical Public Health, Harvard School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Telford Iii, S R" sort="Telford Iii, S R" uniqKey="Telford Iii S" first="S. R." last="Telford Iii">S. R. Telford Iii</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>From the Division of Hematology, Department of Medicine, and the Department of Pathology, Brigham and Women's Hospital; and the Department of Tropical Public Health, Harvard School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Frank, K M" sort="Frank, K M" uniqKey="Frank K" first="K. M." last="Frank">K. M. Frank</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>From the Division of Hematology, Department of Medicine, and the Department of Pathology, Brigham and Women's Hospital; and the Department of Tropical Public Health, Harvard School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Churchill, W H" sort="Churchill, W H" uniqKey="Churchill W" first="W. H." last="Churchill">W. H. Churchill</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>From the Division of Hematology, Department of Medicine, and the Department of Pathology, Brigham and Women's Hospital; and the Department of Tropical Public Health, Harvard School of Public Health, Boston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Transfusion</title>
<title level="j" type="alt">TRANSFUSION</title>
<idno type="ISSN">0041-1132</idno>
<idno type="eISSN">1537-2995</idno>
<imprint>
<biblScope unit="vol">40</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="375">375</biblScope>
<biblScope unit="page" to="380">380</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Blackwell Science Inc</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2000-03">2000-03</date>
</imprint>
<idno type="ISSN">0041-1132</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0041-1132</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Appropriate antimicrobial therapy</term>
<term>Area anemia</term>
<term>Babesia</term>
<term>Babesia microti</term>
<term>Babesiosis</term>
<term>Blood cell separator</term>
<term>Blood exchange</term>
<term>Blood smear</term>
<term>Case report</term>
<term>Clin apheresis</term>
<term>Clindamycin</term>
<term>Clinical course</term>
<term>Clinical improvement</term>
<term>Days parasitemia</term>
<term>Distress syndrome</term>
<term>Exchange transfusion</term>
<term>Fulminant</term>
<term>Fulminant babesiosis</term>
<term>Fulminant disease</term>
<term>General improvement</term>
<term>Hemolytic</term>
<term>Hemolytic anemia</term>
<term>Human babesiosis</term>
<term>Human infection</term>
<term>Indirect immunofluorescence assay</term>
<term>Intravascular coagulation</term>
<term>Laboratory studies</term>
<term>Mechanical ventilation</term>
<term>Microti</term>
<term>Mild illness</term>
<term>Nantucket island</term>
<term>None fever</term>
<term>Oral clindamycin</term>
<term>Oral quinine</term>
<term>Parasite</term>
<term>Parasite load</term>
<term>Parasitemia</term>
<term>Parasitized rbcs</term>
<term>Partial thromboplastin time</term>
<term>Pentamidine parasitemia</term>
<term>Peripheral blood</term>
<term>Peripheral blood smear</term>
<term>Platelet count</term>
<term>Prothrombin time</term>
<term>Pulmonary edema</term>
<term>Quinine</term>
<term>Rbc</term>
<term>Rbcs reconstituted</term>
<term>Renal failure</term>
<term>Resident fever</term>
<term>Respiratory failure</term>
<term>Respiratory function</term>
<term>Risk factors</term>
<term>Risk factors mode</term>
<term>Second hospital</term>
<term>Severe babesiosis</term>
<term>Splenectomized patient</term>
<term>Splenectomy</term>
<term>Splenectomy travel</term>
<term>Total blood volume</term>
<term>Transfusion</term>
<term>Transfusion volume</term>
<term>Whole blood exchange</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">BACKGROUND: Babesiosis is an increasingly recognized parasitic infection with manifestations that range from a subclinical or mild flu‐like illness to life‐threatening disease. Risk factors that may be associated with a more severe clinical course include immunosuppression, splenectomy, and advanced age. The most effective chemotherapeutic regimen, clindamycin plus quinine, is sometimes ineffective in cases of severe disease. CASE REPORT: A previously healthy, 58‐year‐old man was infected by Babesia microti, presumably through a tick bite. He developed fulminant disease characterized by severe hemolytic anemia, disseminated intravascular coagulation, acute renal failure, and respiratory failure. There was no history of splenectomy or immunodeficiency. He was given oral clindamycin (300 mg/4×/day) 2 days before admission. Oral quinine (650 mg/3×/day) was added upon hospitalization. There was no clinical improvement despite antibiotic therapy with clindamycin and quinine. On the second hospital day, a whole‐blood exchange transfusion was performed to simultaneously lower the parasite load and replace the patient's plasma. With an automated blood cell separator, 87 percent of the patient's total blood volume was exchanged. As replacement fluid, 6.7 L of packed RBCs reconstituted with FFP (average Hct, 33%) was used. The patient's Hct increased from 26.9 percent before the exchange to 28.3 percent after the exchange. The percentage of parasitized RBCs decreased from 13.8 percent just before exchange to 4.2 percent immediately after exchange. There was rapid clinical improvement after the whole‐blood exchange transfusion. The patient's subsequent clinical course was marked by a disappearance of the parasitemia and continued slow, general improvement. Therapy with clindamycin was continued for 14 days after the exchange transfusion and quinine for 17 days. CONCLUSION: In cases of severe babesiosis, prompt institution of whole‐blood exchange transfusion, in combination with appropriate antimicrobial therapy, can be life‐saving.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Dorman, S E" sort="Dorman, S E" uniqKey="Dorman S" first="S. E." last="Dorman">S. E. Dorman</name>
</region>
<name sortKey="Cannon, M E" sort="Cannon, M E" uniqKey="Cannon M" first="M. E." last="Cannon">M. E. Cannon</name>
<name sortKey="Churchill, W H" sort="Churchill, W H" uniqKey="Churchill W" first="W. H." last="Churchill">W. H. Churchill</name>
<name sortKey="Frank, K M" sort="Frank, K M" uniqKey="Frank K" first="K. M." last="Frank">K. M. Frank</name>
<name sortKey="Telford Iii, S R" sort="Telford Iii, S R" uniqKey="Telford Iii S" first="S. R." last="Telford Iii">S. R. Telford Iii</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002545 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002545 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3652D775AFC677FB155E1966B626914EE41B459C
   |texte=   Fulminant babesiosis treated with clindamycin, quinine,and whole‐blood exchange transfusion
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021